Skip to main content

Best Ayurvedic Company in India

Manufacturing Batch Record for Cosmetics

I. Particulars to be shown in the manufacturing records:  (1) Serial number.  (2) Name of the product.  (3) Lot or Batch size.  (4) Lot or Batch number.  (5) Date of commencement of manufacture and date when manufacture was completed.  (6) Names of all ingredients, quantities required for the lot/batch size, quantities actually used.  (7) Control reference numbers in respect of raw materials used in formulation.  (8) Reference to analytical report numbers or unique code.  (9) Actual production and packing particulars indicating the size and quantity of finished packings.  (10) Date of release of finished packing for distribution or sale.  (11) Signature of the expert staff responsible for the manufacture.  II. Records of raw materials: Records in respect of each raw material shall be maintained indicating the quantity received, control reference number, the quantity issued from time to time, the names and batch numbers of the products for the manufacture of which the said quantity of r

Schedule Y


Schedule Y (Rule 122A, 122B, 122D, 122DA, 122DAA and 122E):

Schedule Y describes the requirements and guidelines for permission to import and / or manufacture of new drugs for sale or to undertake clinical trials.

1.       Application for Permission
2.       Clinical Trial
I.                    Approval for clinical trial
II.                  Responsibilities of Sponsor
III.                Responsibilities of the Investigator(s)
IV.                Informed Consent
V.                  Responsibilities of the Ethics Committee
VI.                Human Pharmacology (Phase I)
VII.              Therapeutic exploratory trials (Phase II)
VIII.            Therapeutic confirmatory trials (Phase III)
IX.                Post Marketing Trials (Phase IV)
3.       Studies in special populations
I.                    Geriatrics
II.                  Paediatrics
III.                Pregnant or nursing women
IV.                Post Marketing Surveillance
V.                  Special studies: Bioavailability / Bioequivalence Studies

Appendix I: Data to be submitted along with the application to conduct clinical trials/import/manufacture of new drugs for marketing in the country

Appendix IA: Data required to be submitted by an applicant for grant of permission to import and / or manufacture a new drug already approved in the country

Appendix IB: Data to be submitted along with application to conduct clinical trial or import or manufacture of a phytopharmaceutical drug in the country

Appendix II: Structure, contents and format for clinical study reports

Appendix III: Animal toxicology (non-clinical toxicity studies)

Appendix IV: Animal Pharmacology

Appendix V: Informed Consent

Appendix VI: Fix Dose Combinations (FDCs)

Appendix VII: Undertaking by Investigator

Appendix VIII: Ethics Committee

Appendix IX: Stability Testing of New Drugs

Appendix X: Contents of the proposed protocol for conducting clinical trials

Appendix XI: Data Elements for reporting serious adverse events occuring in a clinical trial

Appendix XII: Compensation in case of injury or death during clinical trial

For more detail refer Drug and Cosmetic Act

Comments

Register your business at

Find pharmaceutical, cosmetics, nutraceutical, ayurveda and alternative medicine's distributors, franchise, suppliers query for free.

If you want to take distribution, franchise or associates with any pharmaceutical, cosmetic or ayush company then you can find it here...

Popular posts from this blog

What are the Schedules under Drug and Cosmetic Act, 1940 & Rules 1945?

Schedules are the set of provisions for classifications of drugs, forms, fees, standards, requirements and regulations related to drugs and cosmetics under Drug and Cosmetic Act, 1940 and Rules, 1945. Here drugs includes pharmaceutical, Ayurvedic (including siddha), unani and tibb system of medicines, homeopathy etc. Schedules are divided alphabetically and named also alphabetically like Schedule A, Schedule B etc till Schedule Y. Schedule Z is proposed  but not implemented yet. Schedules are important part of Drug and Cosmetic Act 1940 & Rules, 1945 . Every schedule contains specific information as discussed below. Schedule A:  Schedule A  describes application forms and licenses types. Schedule B:  Schedule B  describes Fees for test or analysis by the Central Drugs Laboratories or State Drugs Laboratories Schedule B1: Schedule B1 describes fees for the test or analysis by the pharmacopoeial laboratory for indian medicine (plim) or the government analyst Schedule C: 

State Pharmacy Council, Its Constitution and Composition and Functions

State Pharmacy Council: State Pharmacy Council is constituted as per the Pharmacy Act, 1948 & State Pharmacy Rules, 1951. State Pharmacy Council is an authoritative council to regulate Pharmacy Act, 1948 & State Pharmacy Rules, 1951. State Pharmacy Council means a State Council of Pharmacy constituted under section 19, and includes a Joint State Council of Pharmacy constituted in accordance with an agreement under section 20 under the Pharmacy Act, 1948 & State Pharmacy Rules, 1951. State Pharmacy Council work under Pharmacy council of india . The State Pharmacy Council consists of the following: (i) Six members, elected from amongst themselves by registered pharmacists (ii) Five members, of whom three are persons possessing a prescribed degree or diploma in pharmacy or pharmaceutical chemistry or registered pharmacist, nominated by State Government (iii) One member, elected from amongst themselves by the members o

Pharmacy Council of India, Its Constitution and Composition and Functions

Pharmacy Council of India: The Pharmacy Council of India is the statutory body of government of India also called as central council constituted under the Pharmacy Act, 1948. The Pharmacy Council of India consists of the following: (i) Six members, among whom at least one teacher of pharmaceutical chemistry, pharmacy. Pharmacology and pharmacology elected by the University Grants Commission. (ii) Six members, four of whom are persons possessing a degree or diploma in and practicing pharmacy or pharmaceutical chemistry, nominated by the Central Government. (iii) One member elected from amongst themselves by the members of the Medical Council of India. (iv) The Director General of Health Services or an authorized person by him. (v) The Drugs Controller of India or an authorized person by him (vi) The Director of Central Drugs Laboratory (vii) A representative of the University Grants Commission